SMAD3 and ductal breast carcinoma in situ: To determine the clinical relevance of CCL2/CCR2 signaling protein expression in breast cancer, we performed immunohistochemistry staining on patient samples of DCIS, IDC and normal adjacent tissues for detection of CCL2, CCR2, phospho-SMAD3 and phospho-42/44MAPK proteins.